economy

Energy Matters

Posted by nicoleatbio on August 24, 2009 at 6:28am EDT

Some say growth in the biofuel industry can play a significant
role in fueling this country's economic engine. For example,
There are about three-dozen cellulosic biorefineries currently in
various stages of planning or construction. Six of these are
Already in operation producing biofuels. Industry analyst BIO
Economic Research Associates projects that advanced biofuel
producers such as these can create more than one-hundred thousand
new jobs by 2022. Many of these jobs will be in
sectors hit hard by the current recession, such as agriculture
and construction.

Corrine Young of Myriant Discusses Biobased Products

Posted by danmcgirt on August 13, 2009 at 11:31am EDT

BIOtech Now interviews Corrine Young, director of government affairs for Myriant Technologies LLC.

U.S. Economic Impact of Advanced Biofuels Production

Posted by susanatbio on March 13, 2009 at 10:53am EDT

A new report by Bio Economic Research Associates (bio-era™), U.S. Economic Impact of Advanced Biofuels Production: Perspectives to 2030, shows that continuing to build advanced biofuels production capacity can create thousands of new jobs throughout the economy, contributing to U.S. economic growth and increasing energy security.

U.S. Economic Impact of Advanced Biofuels Production

Posted by nicoleatbio on February 27, 2009 at 3:53pm EST

A new report by Bio Economic Research Associates (bio-era™), U.S. Economic Impact of Advanced Biofuels Production: Perspectives to 2030, shows that continuing to build advanced biofuels production capacity can create thousands of new jobs throughout the economy, contributing to U.S.

BIO CEO & Investor Conference: Mergers and Acquisitions

Posted by TracyatBIO on February 11, 2009 at 3:44pm EST

In a year of recession, a non-existent IPO window, more cautious public and private investors, and the need to conserve cash, it’s clear why 2008 was the year of M&A.

While the biotech industry is expected to rebound this year, M&A is still top of mind for small biotechs and big pharma.

Small biotechs and big pharma encourage quick movement in this uneasy economy—a “be honest, let go, and move on” mentality to be exact!

Syndicate content